Literature DB >> 576381

Infectious syphilis mimicking neoplastic disease.

L M Drusin, C Singer, A J Valenti, D Armstrong.   

Abstract

Five patients who were initially evaluated for malignant neoplasm actually had infectious syphillis (one primary, two secondaries, two secondaries with persistence of primary). Two patients were considered for radical surgery and one for extensive radiation and/or chemotherapy. In four patients an elevated routine admission VDRL was the first indication of the correct diagnosis. Dark-field examination is the most important laboratory test in the diagnosis of primary syphillis; VDRL and FTA-ABS are most important in confirming secondary syphillis. Penicillin remains the drug of choice for therapy. At a time when the incidence of sexually transmitted diseases is increasing, it is extremely important to develop adequate educational programs for medical students and physicians.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 576381

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  5 in total

1.  Venereal aspects of gastroenterology.

Authors:  R L Owen; S K Dritz; C J Wibbelsman
Journal:  West J Med       Date:  1979-03

Review 2.  Secondary syphilitic lesions.

Authors:  Robert E Baughn; Daniel M Musher
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  [Primary syphilitic lesion mimicking penile cancer. Atypical manifestation with an unconventional diagnostic approach].

Authors:  I Tsaur; F R Ochsendorf; R Bug; D Jonas
Journal:  Urologe A       Date:  2009-10       Impact factor: 0.639

4.  Don't forget syphilis.

Authors:  R D Maw; T Horner
Journal:  Ulster Med J       Date:  1981

5.  Syphilis? An Unusual Cause of Surgical Emergency in a Human Immunodeficiency Virus-Infected Man.

Authors:  Rachel A Bender Ignacio; Lisa L Koch; Shireesha Dhanireddy; B Charmie Godornes; Sheila A Lukehart; Jeanne M Marrazzo
Journal:  Open Forum Infect Dis       Date:  2015-06-20       Impact factor: 3.835

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.